Tanvex BioPharma (Taiwan) Today
| 6541 Stock | TWD 38.10 0.10 0.26% |
Performance0 of 100
| Odds Of DistressOver 65
|
Tanvex BioPharma is selling for under 38.10 as of the 26th of May 2024; that is 0.26 percent increase since the beginning of the trading day. The stock's lowest day price was 38.0. Tanvex BioPharma has more than 65 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Tanvex BioPharma are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of February 2024 and ending today, the 26th of May 2024. Click here to learn more.
Tanvex BioPharma, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar and biologic products and drugs in Taiwan and the United States. Tanvex BioPharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands. The company has 352.74 M outstanding shares. More on Tanvex BioPharma
Moving together with Tanvex Stock
| 0.74 | 4743 | Oneness Biotech | PairCorr |
| 0.8 | 6547 | Medigen Vaccine Biologics | PairCorr |
Moving against Tanvex Stock
| 0.89 | 0050 | YuantaP shares Taiwan | PairCorr |
| 0.88 | 6020 | Tachan Securities | PairCorr |
| 0.87 | 0057 | Fubon MSCI Taiwan | PairCorr |
| 0.86 | 0053 | YuantaP shares Taiwan | PairCorr |
| 0.65 | 0051 | YuantaP shares Taiwan | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Tanvex Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Tanvex BioPharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Tanvex BioPharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Lin Chen |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Tanvex BioPharma (6541) is traded on Taiwan Stock Exchange in Taiwan and employs 23 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 17.11 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Tanvex BioPharma's market, we take the total number of its shares issued and multiply it by Tanvex BioPharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Tanvex BioPharma operates under Healthcare sector and is part of Biotechnology industry. The entity has 352.74 M outstanding shares.
Tanvex BioPharma has accumulated about 1.65 B in cash with (1.39 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.29.
Check Tanvex BioPharma Probability Of Bankruptcy
Ownership AllocationTanvex BioPharma maintains a total of 352.74 Million outstanding shares. Tanvex BioPharma maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Tanvex Ownership Details
Tanvex BioPharma Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Tanvex BioPharma market risk premium is the additional return an investor will receive from holding Tanvex BioPharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Tanvex BioPharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Tanvex BioPharma's alpha and beta are two of the key measurements used to evaluate Tanvex BioPharma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.76 | |||
| Standard Deviation | 2.62 | |||
| Variance | 6.87 | |||
| Risk Adjusted Performance | (0.16) |
Tanvex Stock Against Markets
Picking the right benchmark for Tanvex BioPharma stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Tanvex BioPharma stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Tanvex BioPharma is critical whether you are bullish or bearish towards Tanvex BioPharma at a given time. Please also check how Tanvex BioPharma's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Tanvex BioPharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
| All Next | Launch Module |
Tanvex BioPharma Corporate Management
Elected by the shareholders, the Tanvex BioPharma's board of directors comprises two types of representatives: Tanvex BioPharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tanvex. The board's role is to monitor Tanvex BioPharma's management team and ensure that shareholders' interests are well served. Tanvex BioPharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tanvex BioPharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Val Chen | Director Officer | Profile | |
| Helena Makagiansar | Deputy General Manager-LJB Production Development | Profile | |
| Yongjian Wu | Deputy General Manager-LJB Research & Development | Profile | |
| LungYeh Cho | Director | Profile | |
| Dilip Joshi | VP US | Profile | |
| LeeChiou Chang | Independent Director | Profile |
How to buy Tanvex Stock?
Before investing in Tanvex BioPharma, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Tanvex BioPharma. To buy Tanvex BioPharma stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Tanvex BioPharma. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Tanvex BioPharma stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Tanvex BioPharma stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Tanvex BioPharma stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Tanvex BioPharma, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Tanvex BioPharma?
The danger of trading Tanvex BioPharma is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Tanvex BioPharma is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Tanvex BioPharma. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Tanvex BioPharma is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Tanvex BioPharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Tanvex Stock analysis
When running Tanvex BioPharma's price analysis, check to measure Tanvex BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tanvex BioPharma is operating at the current time. Most of Tanvex BioPharma's value examination focuses on studying past and present price action to predict the probability of Tanvex BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tanvex BioPharma's price. Additionally, you may evaluate how the addition of Tanvex BioPharma to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |